- Home
- Clinical Trials
Vitiligo Study Pukekohe 102
Vitiligo Study
Pukekohe Auckland
Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming vitiligo studies here.
Description
What to expect
Study details
Ages
18 - 75 years old
Duration
The duration of the study is 30 weeks which will include up to 13 scheduled visits to the clinic
Compensation
Participants will be reimbursed up to $5,442
Eligibility Criteria
You may qualify for this study if you:
- Are aged 18 to 75 years
- Weigh between 45 and 130 kg
- Have been diagnosed with non-segmental vitiligo for at least 3 months
- Have vitiligo patches on 4% to 50% of the body - This can be assessed by our study doctors for you.
- Have some vitiligo patches on the face.
Additional criteria will be discussed with you.
Locations
Description
Vitiligo is a long-term skin condition characterised by flat white spots or patches on the skin which may start small and enlarge and change shape over time. The hair from the skin may also become white.
Vitiligo is believed to be an autoimmune condition in which the immune system mistakenly attacks and destroys the cells responsible for producing melanin, the pigment that gives skin its colour.
Vitiligo can significantly affect a person's emotional and psychological well-being. The condition is not painful and does not have significant health consequences, but the psychological impact of the changing appearance of the skin can be substantial for those affected.
What to expect
This study is evaluating the effectiveness of an investigational treatment containing an antibody that is delivered intravenously to inhibit the specific immune responses that are involved in the destruction of pigment producing cells.
If you are interested in participating or learning more about the study, please register your details. Your participation could not only benefit you but also help make a difference in the lives of others suffering from this condition.
This study is now closed
Please note that this study has now closed. However, we encourage you to pre-register your interest for upcoming vitiligo studies here.